Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver
disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence …

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by
chronic ovulation dysfunction and overabundance of androgens; it affects 6–20% of women …

Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both
adverse reproductive and metabolic implications for affected women. However, there is …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Since first described in 1980, 1 nonalcoholic fatty liver disease (NAFLD) is defined as the
accumulation of hepatic fat, as evidenced by radiologic or histologic examination, in the …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease in industrialized countries worldwide, and has become a serious public health issue …

As the global incidence of obesity has increased, nonalcoholic fatty liver disease (NAFLD)
has become a worldwide health concern. NAFLD occurs in children and adults of all …

While the links between metabolic dysfunction associated steatotic liver disease liver
disease (MASLD) and obesity, insulin resistance are widely appreciated, there are a host of …

Postmenopausal women with nonalcoholic steatohepatitis are at an increased risk of
hepatic fibrosis compared with premenopausal women. Whether duration of estrogen …

CONTEXT: Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic
syndrome, has been considered the most common liver disease nowadays, which is also …